The first intra-articular Visco-Antalgic
The V-A Effect: Intense, Fast Prolonged Pain Relief
Intense Pain Relief *
68% average pain reduction at 12 weeks after treatment initiation
Fast Pain Relief **
2/3 of patients are experiencing a noticeable pain relief just one week after the 1st injection
Prolonged Pain Relief **
Over 80% of patients are still experiencing treatment’s benefits 6 months after the 1st injection
A unique combination of Hyaluronic Acid (2%) & sorbitol (4%)
Sorbitol protects Hyaluronic Acid (HA) from degradation
Counterbalancing oxidative stress
Sorbitol is an anti-oxidant that neutralises free radicals that are a major cause of the osteoarthritis evolution
Offering adaptive visco-elasticity
Like healthy human synovial fluid, Synolis V-A displays viscosity & elasticity properties that adapt to the need of lubrication or shock absorption.
* data on file: Non-Interventional Study including a population of: 152 patients with 50% Kellgren Gr. II & 50% Gr. III & with Moderate or Severe Initial Pain, receiving 3 injections of Synolis V-A. Initial average walking pain at 2.6 on 5-point Likert scale.
** data on file: Non-Interventional Study including a population of 997 patients with all level of pain or grades, receiving 1 or 3 injections of Synolis V-A